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Background 
Electroconvulsive therapy (ECT) is the most effective acute treatment for severe depression, but 
widely held concerns about memory problems may limit its use. 
Aims 
To find out whether repeated or maintenance courses of ECT cause cumulative cognitive 
deterioration. 
Method 
Analysis of the results of 10 years of cognitive performance data collection from patients who have 
received ECT. The 199 patients had a total of 498 assessments, undertaken after a mean of 15.3 ECT 
sessions (range 0–186). A linear mixed-effect regression model was used, testing whether an 
increasing number of ECT sessions leads to deterioration in performance. 
Results 
The total number of previous ECT sessions had no effect on cognitive performance. The major 
factors affecting performance were age, followed by the severity of depression at the time of testing 
and the number of days since the last ECT session. 
Conclusions 
Repeated courses of ECT do not lead to cumulative cognitive deficits. This message is reassuring for 
patients, carers and prescribers who are concerned about memory problems and confusion during 
ECT. 
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Electroconvulsive therapy (ECT) is the most effective acute treatment for severe depression,1 with 
reported remission rates above 50%.2,3 Although some reports demonstrate even higher remission 
rates (such as 75% in patients with psychotic depression4), these could be below 50% for treatment-
resistant depression or in community settings.5,6 ECT is often portrayed in mainstream media as a 
barbaric treatment7 and its cognitive side-effects as profound and debilitating, leading to public, 
patient and carer concerns. ECT does cause retrograde amnesia and acute disorientation 
immediately following a treatment,8 however, research has suggested that this is only a short-lived 
side-effect. A meta-analysis by Semkovska & McLoughlin9 analysed the cognitive tests of 2981 
patients from 84 studies, performed before and after single courses of ECT, and found that a decline 
in cognitive performance was limited to the first 3 days following a treatment. Patients showed no 
cognitive deterioration when tested 2 or more weeks after their last ECT session. This does not apply 
to retrograde amnesia, which was not part of this analysis, and it cannot be extended to cognitive 
functions that were not tested. Much less is known about the side-effects of long-term ECT, 
including maintenance ECT. A major concern of patients and some health professionals is that it 
could lead to progressive cognitive deficits, especially if given for prolonged periods of time. Small 
studies and case reports have addressed this question and have found no evidence to support this 
concern (see Discussion). Over the past 10 years we performed prospective cognitive tests on 199 
patients, of whom 96 had 412 ECT sessions during their lifetime (the usual maximum duration of a 
single ECT course). We wanted to find out whether there was evidence that their cognitive 
performance deteriorated with the increasing number of ECT sessions. 
Method 
We introduced cognitive testing for ECT patients at our department in 2004, first as part of a study 
comparing ECT and magnetic seizure therapy.10 Influenced by the general perceptions at that time, 
we expected that ECT would cause a deterioration in cognitive tests. We found the tests very useful 
when making decisions about repeated ECT courses or maintenance ECT and when addressing 
patients’ concerns. Therefore, we introduced these tests as part of the standard assessments of 
patients. More recently routine cognitive testing was recommended by the ECT Accreditation 
Service (ECTAS) of the Royal College of Psychiatrists. The list of nine tests that we use is presented in 
the Appendix.9,11,12 Tests were administered by the authors of this paper, staff at the ECT 
department, students or psychiatrists at Cardiff University, as part of their projects over the years. 
All raters were trained and supervised in administering the tests by the first author. Therefore this is 
a non-masked study, with all the potential biases arising from such studies. However, the tests have 
been administered by many people, who might have had different expectations and could not know 
how the results could be analysed, therefore we cannot identify any systematic bias that has 
operated on the scoring. All patients who were referred for ECT were offered cognitive testing. Not 
everybody wanted to be tested and the more impaired patients were not able to perform some or 
all of the tests. Tests were performed before the start of a course, within 1 week after its end and at 
3-month follow-up. Over the 10 years, many patients came for repeated courses and were offered 
repeated testing. Some patients required maintenance ECT (for example 11 patients had 450 ECT 
sessions) and we were initially concerned that they would experience a progressive cognitive 
deterioration. We wanted to monitor this and introduced yearly testing of patients having 
maintenance ECT. 
Patients had between 0 and 186 previous ECT sessions at the time of their tests. A total of 199 
patients were assessed on between one and seven occasions. The number of assessments on any 
single test varied between 332 and 493, as some tests were introduced later and not everybody 
completed all tests at each assessment point as a result of refusal, time constraints or technical 
problems. 
We excluded patients with schizophrenia, because of their known cognitive deficits.13 Patients who 
were not fluent in English were not included in this analysis. 
The mean age of patients at the time of their last assessment was 56.3 years (s.d. = 15.8, range 21–
88) and 71.9% of them were female (n = 143). The majority had unipolar depression (n = 166, 
83.4%), the remaining 33 had bipolar affective disorder, but everybody included in this analysis was 
treated for depressive episodes. The average number of ECT sessions that patients had prior to their 
tests was 15.3 (s.d. = 23.2, range 0–186). Figure 1 shows the distribution of the numbers of ECT 
sessions that patients had prior to their tests. 
Statistical analysis 
Our aim was to evaluate whether the cumulative number of ECT sessions received during the 
lifetime of patients prior to testing was inversely correlated with their performance on the cognitive 
tests. We obtained histories of previous courses and recorded the total number of ECT sessions they 
had received prior to each test. As other factors can influence cognitive performance, we included 
the following four covariates: age, number of days since last ECT session, severity of depression and 
the number of times the patient had undertaken the test previously. Age is an obvious confounder, 
as cognitive performance declines with age. It has been shown that cognitive performance is worse 
in the first 3 days after an ECT session and tends to improve with time.9 We recorded the number of 
days since the last ECT session (for those who had no previous ECT sessions, we entered an arbitrary, 
but very large number of 10 000 days (about 30 years), in order to keep these assessments in the 
analysis). As these data were extremely skewed, we log-transformed the number of days since the 
last ECT. As our cognitive testing always includes an objective measure of the severity of depression 
(the 24-item Hamilton Rating Scale for Depression, HRSD-24),14 we included these scores as a 
covariate, expecting that patients who were more severely depressed might perform worse. The 
number of times a test had been undertaken previously by a patient was also included as a covariate 
in order to control for the possibility that patients improve their performance with practice. As some 
patients had undertaken tests on more occasions than others (between one and seven occasions), 
we also wanted to control for the potentially disproportionate effect of inter-individual differences. 
We there-fore used a linear mixed-effect regression model with random effects attributed to 
individual patients and fixed effects to the four covariates listed above. We used the R statistical 
package with the library lme4 (function lmer). As a secondary analysis we compared the first and last 
cognitive tests of those patients who had 13 or more ECT sessions between these tests (more than a 
standard ECT course of 12 sessions). We used a paired samples t-test to compare these pre- and 
post-ECT results. 
Results 
Results are presented in Table 1. We show the effect size and statistical significance of the effect 
from the number of ECT sessions and the four covariates on cognitive performance. Effect size 
denotes the change on the cognitive score with each unit of the covariate (such as each year of age 
or each ECT session). Deterioration is always indicated with a negative sign of the effect size, 
whether it refers to reduction in score (for example verbal fluency), or increase in the time needed 
to perform a test (Trail Making and Reaction Time), or increase in the Cognitive Failures 
Questionnaire (CFQ) score.9,11 The number of ECT sessions prior to testing had no significant effect 
on any of the tests. The other covariates had statistically significant effects on the results, in the 
predicted directions. 
The variable with the strongest effect on the tests was age, with performance significantly declining 
with increasing age on all tests except the CFQ. The CFQ is a self-assessment of cognitive/memory 
problems and the results suggested that older patients complained less of cognitive problems. The 
next factor influencing the results was the severity of depression at the time of testing, which 
adversely (and significantly) affected seven of the nine tests. 
 
 
Patients showed significant improvements in performance with increasing time-gaps since the last 
ECT session on two of the tests (memory and Trail Making A). Practice (repetition of the tests) 
significantly improved the performance on two tests (Reaction Time and Trail Making A). 
As a secondary analysis we compared the pre- and post-ECT results on 55 patients who had 13 or 
more ECT sessions between their first and last cognitive assessment (i.e. more than the standard 
duration of a single ECT course of up to 12 sessions). The median number of ECT sessions these 
patients had between the tests was 20 (range 13–156). We used paired samples t-tests and present 
the results in Table 2. All results improved, two of them improved significantly. The improvements 
are most likely because of improvements in depression at the end of a course or at follow-up (HRSD-
24 scores were on average 29.1 at the first and 14.7 at the time of the last tests). 
Discussion 
Findings from other studies 
Memory problems and fears of cognitive decline are probably the biggest deterrents for patients’ 
willingness to undergo ECT.15 The internet abounds with reports of people complaining that ECT has 
destroyed their memory and mainstream media tends to portray it as a barbaric treatment.7 
Complaints of memory loss regarding events occurring around, or a few months prior to ECT courses 
(retrograde amnesia) are very frequent and were also reported by many of our patients (the tests in 
the Appendix do not measure retrograde amnesia). However, a meta-analysis9 showed that the 
reduced performance on various cognitive tests is limited to only the first few days after a ECT 
session, and tends to improve when such tests are performed more than 2 weeks after the last 
session. However, the improvement of depression after ECT could have improved performance and 
masked a small underlying cognitive deterioration (we were able to control for depression severity in 
the current study). There is less evidence as to whether repeated courses of ECT, or maintenance 
ECT given over several years, will result in cumulative cognitive deficits. It is conceivable that some 
small damage is caused by each ECT, which could be overlooked if testing is limited to 3–12 sessions, 
the typical duration of the majority of ECT courses included in the meta- analysis.9 It is impractical to 
conduct such studies as part of masked, control trials, as they require years of observations and 
testing patients who might lose capacity to provide informed consent at some periods of their 
treatments. Most of the evidence on long ECT courses is from case reports and small case series and 
they show lack of cumulative deterioration. Case reports by Wijkstra & Nolen16 on a patient who 
received 244 ECT sessions over 7 years, Barnes et al17 on a patient who had 420 ECT sessions and 
Zisselman et al18 on a patient who had 12 months of weekly maintenance ECT found no evidence of 
progressive deterioration on the Mini-Mental Sate Examination (MMSE). Russell et al19 conducted a 
retrospective chart review of MMSE scores of 43 patients who had received at least 1 year of 
maintenance ECT and found a small, not significant improvement in the mean scores. Abraham et 
al20 tested memory changes in 18 patients who had received at least 3 months of maintenance ECT. 
‘Mild memory impairment’ affected just three patients, whereas severe memory changes were only 
found in one patient. Vothknecht et al21 reported on 11 patients who underwent maintenance ECT 
and who received sessions on average 2.2 weeks apart and who were tested with a battery of 
neuropsychological tests at baseline and after 6 months. The results actually improved after 6 
months of maintenance ECT. It has been suggested that the risk of cognitive impairment during 
longer courses of maintenance ECT may even decrease, because of the longer time intervals 
between sessions.22 
Main findings 
To our knowledge, the current study is the first of its kind, reporting on 10 years of cognitive data 
collection on consecutive ECT patients, where each patient’s lifetime number of ECT sessions has 
been recorded and included in the analysis. Our results show a lack of cumulative cognitive 
deterioration with an increasing number of ECT sessions. In contrast, other covariates, such as age 
and severity of depression, produced clear trends in the expected directions, suggesting that we 
have not missed trends where they exist, because of noise in the data or bias that can occur in an 
open study. An example of this is presented in Fig. 2 that shows a clear deterioration of the scores 
on the Complex Figure test12 with increasing age of the patients, but there is no such trend with 
increasing number of ECT sessions. The results are supported by our observations on patients who 
accumulated the highest numbers of ECT sessions over the 10-year period of monitoring and 
showed no deterioration in their performance (Table 2). 
 
 
 
 
 
 Limitations 
As an open, uncontrolled study, our work has limitations that we acknowledge. For example, some 
patients might have had early stages of dementia or underlying cerebrovascular disease, which could 
lead to a reduced cognitive reserve. To reduce this potential problem, we re-analysed the results 
while excluding people over the age of 65. The lack of effect from the number of ECT sessions 
remained for all cognitive tests (data not presented). The effect size caused by age was reduced, as 
expected, but remained in the same direction. It is also possible that the patients who persist with 
more ECT sessions may be those who had fewer cognitive side-effects, so that those who have more 
ECT sessions will tend to have fewer adverse effects. This potential bias is difficult to address in a 
naturalistic study, and we can only report that many of our patients on maintenance ECT or 
repeated courses complained of subjective memory problems and stopped their treatments on 
many occasions, i.e. they did not appear to be more tolerant of side-effects. We were unable to 
measure any cumulative retrograde amnesia because of the longitudinal nature of the testing 
(patients are more likely to forget the original events, if tested 1 or more years later, when they 
come for new ECT courses). 
Implications 
We find that discussing the cognitive results with patients is highly reassuring for them, as they can 
see for themselves that their cognitive performance remains stable. This has helped their decisions 
when accepting further ECT courses or maintenance treatment, something that might have been 
unacceptable to them or to their treatment teams only a few years ago. Our results suggest that 
patients can have repeated courses or maintenance ECT without this resulting in long-term 
cumulative cognitive deterioration. We hope that this study will help to counter the negative public 
view of ECT, which may be having an effect on prescribers and thus aid in the appropriate 
prescribing of this effective treatment. 
Appendix 
List of cognitive tests and the functions they measure 
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